MAVIS Hub Edition 131
Published 14 August 2024
1. Product News
Recall notice for Kexxtone 32.4g Continuous-Release Intraruminal Device for Cattle - 30 July 2024
Aquacare Swimbladder Treatment Product defect recall alert - 29 July 2024
Caninsulin 40 IU/ml Suspension for Injection – Adverse events - 19 July 2024
Fleasolve 134 mg Spot-on Solution for Medium Dogs - Product defect recall alert - 5 July 2024
Neptra Ear Drops Solution for Dogs – SPC change - 27 June 2024
Cimalgex 8 mg / 30 mg / 80 mg Chewable Tablets for Dogs – SPC change - 20 June 2024
Propalin Syrup, 40 mg/ml Dogs – SPC change - 20 June 2024
Product defect alert - Johnson’s 4Fleas Tablets for Cats and Kittens - 14 June 2024
Warning relating to veterinary use of human eye gels - 2 May 2024
2. Enforcement
Mutoral II for feline chronic gingivostomatitis (FCGS) seized - 20 June 2024
Artikrill Dol Cane seized - 20 June 2024
Operation Ancord – Multiple seizures of veterinary products - 13 June 2024
UK prescription veterinary medicine seized - 31 May 2024
Non-UK authorised worming tablets seized - 31 May 2024
Animal supplements seized - 23 May 2024
Pet supplements seized - 23 May 2024
Joint supplement for dogs seized - 8 May 2024
Dog worming granules seized - 8 May 2024
Five vasodilator injectable medicines for dogs and horses seized - 8 May 2024
Worming medicines for cats and dogs seized - 8 May 2024
3. AMR (Antimicrobial Resistance)
3.1 AMR National Action Plan 2024-2029
The AMR National Action Plan (2024-2029) is now published. This action plan is co-owned by DHSC and Defra and sets out the UK’s comprehensive One Health approach to tackling AMR.
3.2 International Engagement
UNGA AMR High-Level Meeting 2024
VMD is working across and beyond government to achieve a strong global declaration on AMR at the AMR High-Level Meeting (HLM) at the UN General Assembly in September 2024. In May, the VMD supported an event held by the Royal Society and UK Government celebrating and galvanising global efforts to tackle AMR, attended by International ministers, civil society, industry and included a keynote speech from His Royal Highness the Prince of Wales. VMD have been supporting UK CVO’s role on the Steering Committee of the Quadripartite AMR Multistakeholder platform which represents national governments.
International Engagement
The VMD have been engaging internationally at a broad range of global events including an AMR conference hosted by the Belgian presidency, a Quadripartite Regional Benchmarking Workshop on AMR surveillance organised by FAO Regional Asia Pacific and the WOAH General Assembly where UK CVO and Swedish CVO hosted a AMR side event for over 30 CVOs with VMD’s support. VMD are delivering a postgraduate programme in partnership with the University of Zambia. This postgraduate programme in collaboration with Fleming Fund facilitates research on antimicrobial resistance and antimicrobial use within the animal health industry.
3.3 Surveillance Activities
PATH-SAFE
We completed AMR projects within the Pathogenic Surveillance in Agriculture, Food and Environment (PATH-SAFE) Programme, led by FSA. These projects have generated representative data on bacterial prevalence and AMR for animal species outside our established harmonised monitoring programmes, working collaboratively with stakeholder organisations in the process. The results of these projects will be published in this year’s UK-VARSS report and in peer reviewed publications in due course.
National Biosurveillance Network (NBN)
VMD is leading a workstream within the NBN, alongside APHA and Defra. We aim to address barriers and identify incentives for sharing AMR data from private veterinary labs to government. This builds upon existing work conducted through the Private Laboratories Initiative (PLI).
3.4 Antibiotic Usage and Stakeholder Engagement
The antibiotic use, stewardship and stakeholder engagement team continue to work closely with a range of stakeholders to ensure that the AMR provisions of the updated Veterinary Medicines Regulations are clear and stakeholders understand the changes. We continue to work with industry to collect usage and sales data ahead of publishing the new UK-VARSS report later this year.
3.5 DARC
The Defra Antimicrobial Resistance Coordination (DARC) group held a meeting on 10 June 2024. The meeting included an update on recent findings from across the UK on AMR in bacteria of importance to animal and public health. The meeting focussed on understanding the potential animal and public health risks of raw pet food. Minutes from previous meetings are available on GOV.UK.
Antimicrobial resistance (AMR) - 8 May 2024
4. Guidance Updates
Apply for Specific Manufacturing Authorisation - 17 July 2024
Marketing authorisations for veterinary medicines - 9 July 2024
Further changes to our special imports digital service - 1 July 2024
Veterinary Medicines Registers: manufacturing and distribution - 20 June 2024
Change to procedure for joint label assessment for new Marketing Authorisation applications - 2 May 2024
5. Surveillance
Residues of veterinary medicines in food: 2024 - 18 July 2024
6. Statistics
Top Ten Imported Veterinary Medicines – Quarterly Report 1 April to 30 June 2024 - 16 July 2024
VMD Published Standards 2024 to 2025: Monitoring performance - 6 June 2024
Published standards for regulatory work 2024/2025 - 13 May 2024
7. Stakeholder Engagement
Introductory Veterinary Wholesale Qualified Person Training Course - 25 July 2024
Customer Survey Results 2024 - 25 June 2024
VICH consultation on safety of residues of veterinary drugs in human food - 10 June 2024
8. Corporate News
VMD Corporate Priorities 2024 - 2025 - 24 July 2024
Veterinary Medicines Directorate – Our governance - 28 June 2024